ASE Technology Holding Co., Ltd. American Depositary Shares (each representing (ASX)
9.9800
+0.2400 (2.46%)
Ase Industrial Holding Ltd is a multifaceted company engaged in the design, manufacture, and distribution of various industrial products and solutions
Specializing in advanced materials and innovative manufacturing processes, the company serves a wide range of sectors, including construction, automotive, and electronics. By focusing on sustainability and technological advancements, Ase Industrial Holding aims to provide high-quality, efficient, and environmentally friendly products that meet the evolving needs of its customers. The company is committed to driving growth through strategic partnerships and investments in research and development.
Previous Close | 9.740 |
---|---|
Open | 9.860 |
Bid | 9.940 |
Ask | 10.31 |
Day's Range | 9.700 - 10.20 |
52 Week Range | 8.100 - 12.86 |
Volume | 20,121,152 |
Market Cap | 43.99B |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | 0.3220 (3.23%) |
1 Month Average Volume | 10,829,031 |
News & Press Releases

– Esperion to Receive an Upfront Payment and Near-Term Milestones Along with a Profitable Transfer Price on Product Sales –
By Esperion Therapeutics, Inc. · Via GlobeNewswire · March 3, 2025

Monthly Active Users Reached Approximately 79.6 million Record Annual Global Net Additions to Paying Circles of 457 thousand - Reaching Nearly 2.3 millionTotal Quarterly Revenue Grew 33% Year-Over-Year to $115.5 million Annualized Monthly Revenue increased 34% Year-Over-Year to $367.6 millionAchieved Positive Net Income in Q4 and Record Positive Adjusted EBITDA of $45.5 million for the Year
By Life360, Inc. · Via GlobeNewswire · February 27, 2025

AI Data Science platform will empower smarter, targeted advertising solutions while preserving privacy
By Life360, Inc. · Via GlobeNewswire · February 27, 2025

Share price rose about 19% in the past year from $8.59 to $10.21, as of Friday’s market close.
Via Talk Markets · January 6, 2025

ASE Technology Holding opens new chip packaging and testing facility in Penang, Malaysia, boosting the country's role in global semiconductor industry.
Via Benzinga · February 18, 2025

ASE has officially launched its fifth plant in Penang, which will significantly build on the company’s strong packaging and testing capabilities in the Bayan Lepas Free Industrial Zone. The new plant is part of a strategic expansion plan that will expand the floor space of ASE’s Malaysia facility from its current area of 1 million square feet to approximately 3.4 million square feet.
By Advanced Semiconductor Engineering, Inc. · Via Business Wire · February 18, 2025

– Funds to be used primarily to advance development of ATH434 in Parkinsonian Disorders –
By ALTERITY THERAPEUTICS LIMITED · Via GlobeNewswire · February 10, 2025

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · February 7, 2025

SAN FRANCISCO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Life360, Inc. (Nasdaq: LIF; ASX: 360), the leading family safety and location services company, will release its financial results for the fourth quarter and full year ended December 31, 2024, on Thursday, February 27, 2025 (U.S. PT) / Friday, February 28, 2025 (AEDT).
By Life360, Inc. · Via GlobeNewswire · January 31, 2025

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · January 30, 2025

– Clinically Meaningful Benefit Observed at Both ATH434 Doses Studied –
By ALTERITY THERAPEUTICS LIMITED · Via GlobeNewswire · January 30, 2025

President Donald Trump's pledge to impose sweeping tariffs on imports from Taiwan is raising concerns across semiconductor and pharmaceutical industries, particularly affecting Taiwan Semiconductor Manufacturing Co., the world's largest contract chipmaker.
Via Benzinga · January 28, 2025

Highlights
By ALTERITY THERAPEUTICS LIMITED · Via GlobeNewswire · January 24, 2025

MELBOURNE, Australia and SAN FRANCISCO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today issued a letter to shareholders.
By ALTERITY THERAPEUTICS LIMITED · Via GlobeNewswire · January 9, 2025

HOUSTON and LONDON, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQBKR), an energy technology company, announced Monday an order from Bechtel Energy Inc. (Bechtel) to supply gas technology equipment for two liquefaction plants with a total capacity of approximately 11 MTPA for Phase 1 of Woodside Energy Group Ltd’s (ASX: WDS; NYSE: WDS) (Woodside) Louisiana LNG development opportunity. The order marks a significant milestone as Woodside targets final investment decision (FID) readiness from the first quarter of 2025.
By Baker Hughes · Via GlobeNewswire · December 30, 2024

ASE Technology Holding Co., Ltd. (ASE, TAIEX: 3711, NYSE: ASX), the leading provider of semiconductor packaging, test, and system assembly services, today announced that it has been recognized for its remarkable ESG performance with an inclusion on the 2024 Dow Jones Sustainability Indices (DJSI) World and Emerging Markets. The DJSI are float-adjusted market capitalization weighted indices that measure the performance of companies selected using environmental, social and governance (ESG) criteria. This year, 71 large cap companies were assessed in the Semiconductors and Semiconductor Equipment Industry Group for eligibility to be included on the 2024 DJSI World and only 8 including ASE successfully made the cut. This marks the ninth consecutive year that ASE has made the list.
By ASE Technology Holding Co., Ltd. · Via Business Wire · December 23, 2024

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · December 12, 2024

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · December 9, 2024

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · December 6, 2024

– ATH434 is a Disease Modifying Drug Candidate Targeting Alpha-Synuclein and Iron in Parkinsonian Disorders –
By ALTERITY THERAPEUTICS LIMITED · Via GlobeNewswire · December 4, 2024

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · December 3, 2024

Attributes 278% revenue growth to continued focus and execution of key strategic growth pillars
By Life360, Inc. · Via GlobeNewswire · November 21, 2024

MELBOURNE, Australia and SAN FRANCISCO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), has announced the appointment of Abby Macnish Niven as Alterity’s Company Secretary following her appointment as Chief Financial Officer of Alterity. Ms Macnish Niven assumes the role of Company Secretary from Mr Phillip Hains effective on 18 November 2024.
By ALTERITY THERAPEUTICS LIMITED · Via GlobeNewswire · November 19, 2024

Monthly Active Users Reached Approximately 76.9 million for the QuarterRecord Global Net Additions to Paying Circles of 159 thousand - Reaching Nearly 2.2 million TotalTotal Revenue Grew 18% Year-Over-Year to $92.9 million Annualized Monthly Revenue increased 30% Year-Over-Year to $336.2 millionRaising Outlook for 2024 Adjusted EBITDA
By Life360, Inc. · Via GlobeNewswire · November 12, 2024